Myriad Genetics buy The Goldman Sachs Group, Inc.
Start price
07.05.25
/
50%
€4.00
Target price
07.05.26
€7.05
Performance (%)
-14.30%
End price
08.05.26
€3.43
Summary
This prediction ended on 08.05.26 with a price of €3.43. The price of Myriad Genetics has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -14.30%. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Myriad Genetics | -1.126% | -1.126% | 10.216% |
| iShares Core DAX® | -2.680% | 2.021% | 3.062% |
| iShares Nasdaq 100 | 0.725% | 2.753% | 34.396% |
| iShares Nikkei 225® | -0.725% | 5.698% | 63.753% |
| iShares S&P 500 | 1.166% | 4.063% | 25.141% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $14.00 to $8.00. They now have a "buy" rating on the stock.
Ratings data for MYGN provided by MarketBeat
In the thread Trading Myriad Genetics
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten